These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urologist Practice Structure and Spending for Prostate Cancer Care. Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672 [TBL] [Abstract][Full Text] [Related]
3. Health care delivery system contributions to management of newly diagnosed prostate cancer. Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511 [TBL] [Abstract][Full Text] [Related]
4. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652 [TBL] [Abstract][Full Text] [Related]
5. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605 [TBL] [Abstract][Full Text] [Related]
6. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer. Mitchell JM; Gresenz CR Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758 [TBL] [Abstract][Full Text] [Related]
7. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer. Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425 [TBL] [Abstract][Full Text] [Related]
8. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States. Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610 [TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. Agochukwu-Mmonu N; Qin Y; Kaufman S; Oerline M; Vince R; Makarov D; Caram MV; Chapman C; Ravenell J; Hollenbeck BK; Skolarus TA JCO Oncol Pract; 2023 May; 19(5):e763-e772. PubMed ID: 36657098 [TBL] [Abstract][Full Text] [Related]
10. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764 [TBL] [Abstract][Full Text] [Related]
11. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer. Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728 [TBL] [Abstract][Full Text] [Related]
12. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey. Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706 [TBL] [Abstract][Full Text] [Related]
13. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study. Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402 [TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients. Shah S; Young HN; Cobran EK Am J Mens Health; 2018 Sep; 12(5):1681-1691. PubMed ID: 29877137 [TBL] [Abstract][Full Text] [Related]
15. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016. Ong WL; Evans SM; Evans M; Tacey M; Dodds L; Kearns P; Milne RL; Foroudi F; Millar J Eur Urol Oncol; 2021 Apr; 4(2):319-322. PubMed ID: 31411964 [TBL] [Abstract][Full Text] [Related]
16. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144 [TBL] [Abstract][Full Text] [Related]
17. Understanding Active Surveillance for Prostate Cancer. Lai LY; Shahinian VB; Oerline MK; Kaufman SR; Skolarus TA; Caram MEV; Hollenbeck BK JCO Oncol Pract; 2021 Nov; 17(11):e1678-e1687. PubMed ID: 33830822 [TBL] [Abstract][Full Text] [Related]
18. Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer. Quek RG; Ward KC; Master VA; Lin CC; Portier KM; Virgo KS; Lipscomb J J Natl Compr Canc Netw; 2015 Mar; 13(3):303-9. PubMed ID: 25736007 [TBL] [Abstract][Full Text] [Related]
19. Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer. Dall'Era MA; Lo MJ; Chen J; Cress R; Hamilton AS Cancer; 2018 May; 124(9):1921-1928. PubMed ID: 29499075 [TBL] [Abstract][Full Text] [Related]
20. Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System. Loeb S; Byrne NK; Wang B; Makarov DV; Becker D; Wise DR; Lepor H; Walter D Eur Urol; 2020 Jun; 77(6):683-686. PubMed ID: 32098730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]